Subscribe To
Iberdrola s.a. (ibdsf) ceo ignacio galan on q4 2021 results - earnings call transcript
Iberdrola S.A. (ibdSF) CEO Ignacio Galan on Q4 2021 Results - Earnings Call Transcript...
February 23, 2022, 11:28 am
Iberdrola s.a. (ibdsf) ceo ignacio galan on q4 2021 results - earnings call transcript
Iberdrola S.A. (ibdSF) CEO Ignacio Galan on Q4 2021 Results - Earnings Call Transcript...
February 23, 2022, 11:28 am
Option trade: oil stocks continues to outperform; consider this bullish trade
Today we're looking at a bullish option play in recent ibd Stock Of The Day Williams Companies. As oil ...
February 2, 2022, 3:16 pm
Option trade: oil stocks continues to outperform; consider this bullish trade
Today we're looking at a bullish option play in recent ibd Stock Of The Day Williams Companies. As oil ...
February 2, 2022, 3:16 pm
Option trade: oil stocks continues to outperform; consider this bullish trade
Today we're looking at a bullish option play in recent ibd Stock Of The Day Williams Companies. As oil ...
February 2, 2022, 3:16 pm
Abivax: potentially the next arena pharmaceuticals, most ideal big pharma m&a target in 2022
Arena Pharmaceuticals got acquired by Pfizer for US$ 6.7 Bn (~100% valuation) on December 12th. As a result, the market for late-stage oral ...
December 15, 2021, 10:13 pm
Abivax: potentially the next arena pharmaceuticals, most ideal big pharma m&a target in 2022
Arena Pharmaceuticals got acquired by Pfizer for US$ 6.7 Bn (~100% valuation) on December 12th. As a result, the market for late-stage oral ...
December 15, 2021, 10:13 pm
Abivax: potentially the next arena pharmaceuticals, most ideal big pharma m&a target in 2022
Arena Pharmaceuticals got acquired by Pfizer for US$ 6.7 Bn (~100% valuation) on December 12th. As a result, the market for late-stage oral ...
December 15, 2021, 10:13 pm
Surrozen's inflammatory bowel disease candidate shows encouraging preclinical action
Surrozen Inc (NASDAQ: SRZN) announced that preclinical data from its inflammatory bowel disease (ibd...
October 6, 2021, 7:17 am
Surrozen's inflammatory bowel disease candidate shows encouraging preclinical action
Surrozen Inc (NASDAQ: SRZN) announced that preclinical data from its inflammatory bowel disease (ibd...
October 6, 2021, 7:17 am
Surrozen's inflammatory bowel disease candidate shows encouraging preclinical action
Surrozen Inc (NASDAQ: SRZN) announced that preclinical data from its inflammatory bowel disease (ibd...
October 6, 2021, 7:17 am